Harmon, Cathal
Zaborowski, Alexandra
Moore, Haim
St. Louis, Pamela
Slattery, Karen
Duquette, Danielle
Scanlan, John http://orcid.org/0009-0001-9559-4731
Kane, Harry
Kunkemoeller, Britta
McIntyre, Claire L. http://orcid.org/0000-0003-2489-7724
Scannail, Aine Ni
Moran, Bruce
Anderson, Ana C. http://orcid.org/0000-0002-0877-2932
Winter, Des
Brennan, Donal
Brehm, Michael A.
Lynch, Lydia http://orcid.org/0000-0002-4273-4681
Article History
Received: 8 July 2022
Accepted: 5 June 2023
First Online: 20 July 2023
Competing interests
: L.L. is a member of the scientific advisory board for MiNK Therapeutics and a consultant for Bayer. A.C.A. is a member of the scientific advisory board for Tizona Therapeutics, Trishula Therapeutics, Compass Therapeutics, Zumutor Biologics, ImmuneOncia and Nekonal Sarl. A.C.A. is also a paid consultant for iTeos Therapeutics, Larkspur Biosciences and ExcepGen. The interests of L.L. and A.C.A. were reviewed and managed by the Brigham and Women’s Hospital and Partners Healthcare in accordance with their conflict-of-interest policies. The other authors declare no competing interests.